Remote Vaccination Program To Reduce the Prevalence of Brucellosis in Yellowstone Bison, Final Environmental Impact Statement, Yellowstone National Park, Wyoming, 2688 [2014-00636]

Download as PDF 2688 Federal Register / Vol. 79, No. 10 / Wednesday, January 15, 2014 / Notices publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. We will make all submissions from organizations and businesses, and from individuals identifying themselves as representatives or officials of organizations or businesses, available for public inspection in their entirety. Dated: July 12, 2013. John Wessels, Regional Director, Intermountain Region, National Park Service, Editorial Note: This document was received at the Office of the Federal Register January 3, 2014. [FR Doc. 2014–00078 Filed 1–14–14; 8:45 am] BILLING CODE P DEPARTMENT OF THE INTERIOR National Park Service [NPS–IMR–YELL–14103; PPIMYELL82, PPMRSNR1Z.AM0000] Remote Vaccination Program To Reduce the Prevalence of Brucellosis in Yellowstone Bison, Final Environmental Impact Statement, Yellowstone National Park, Wyoming National Park Service, Interior. Notice of Availability. AGENCY: ACTION: Pursuant to the National Environmental Policy Act of 1969, 42 U.S.C. 4332(2)(C), the National Park Service announces the availability of a Final Environmental Impact Statement for the Remote Vaccination Program to Reduce the Prevalence of Brucellosis in Yellowstone Bison, Yellowstone National Park, Wyoming. DATES: The National Park Service will execute a Record of Decision (ROD) no sooner than 30 days following publication by the Environmental Protection Agency of the Notice of Availability of the Final Environmental Impact Statement. ADDRESSES: Information will be available for public inspection online at http://parkplanning.nps.gov/YELL, and at the Yellowstone Center for Resources, P.O. Box 168, Yellowstone National Park, Wyoming 82190, telephone (307) 344–2203. FOR FURTHER INFORMATION CONTACT: Jennifer Carpenter or Rick Wallen, P.O. Box 168, Yellowstone National Park, WY 82190, telephone (307) 344–2203, or by email at YELL_Bison_ Management@NPS.GOV. SUPPLEMENTARY INFORMATION: The document describes three management wreier-aviles on DSK5TPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 14:04 Jan 14, 2014 Jkt 232001 alternatives including a no-action alternative and the NPS preferred alternative. The anticipated environmental impacts of those alternatives are analyzed. The final document also includes responses to substantive comments from the public, from traditionally associated American Indian tribes, and from government agencies. Alternative A (No Action) describes the currently authorized syringe vaccination of calves and yearlings that are periodically captured at the park boundary. Alternative B describes a proposed action to continue the syringe vaccination program and add a field program to remotely vaccinate calves and yearlings using a pneumatic rifle to deliver an absorbable projectile with a vaccine payload to muscle tissue. Alternative C describes a program to continue the syringe vaccination action and add a field program to remotely vaccinate calves, yearlings, and adult females as is described in Alternative B. The National Park Service has identified Alternative A, No Action, as its preferred alternative based on substantial uncertainties associated with vaccine efficacy, delivery, duration of the vaccine-induced protective immune response, diagnostics, and bison behavior, existing management flexibilities, and evaluation of public comments. Consistent with the 2000 Interagency Bison Management Plan (IBMP), the preferred alternative would continue hand-syringe vaccination of bison at capture facilities near the park boundary and conduct monitoring and research on the relationship between vaccine-induced immune responses and protection from clinical disease (e.g., abortions). Also, selective culling of potentially infectious bison based on age and diagnostic test results may be continued at capture facilities to reduce the number of abortions that maintain the disease. The preferred alternative would continue the adaptive management program, as described in the 2000 Record of Decision for the IBMP and subsequent adaptive management adjustments, to learn more about the disease brucellosis and answer uncertainties, as well as to develop or improve suppression techniques that could be used to facilitate effective outcomes, minimize adverse impacts, and lower operational costs of efforts to reduce brucellosis prevalence in the future. The National Park Service would also continue to work with other federal and state agencies, American Indian tribes, academic institutions, nongovernmental organizations, and other interested parties to develop holistic PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 management approaches, monitoring and research projects that could be conducted to improve the adaptive management decision process, and better vaccines, delivery methods, and diagnostics for reducing the prevalence of brucellosis in bison and elk and transmissions to cattle. Dated: October 31, 2013. Laura E. Joss, Acting Regional Director, Intermountain Region, National Park Service. [FR Doc. 2014–00636 Filed 1–14–14; 8:45 am] BILLING CODE 4312–CB–P DEPARTMENT OF THE INTERIOR National Park Service [NPS–SER–EVER–14535; PX.P0078991D.00.1] Draft Environmental Impact Statement for the Acquisition of Florida Power and Light Company Land in the East Everglades Expansion Area, Everglades National Park, Florida National Park Service, Interior. Notice of availability. AGENCY: ACTION: Pursuant to Section 102(2)(C) of the National Environmental Policy Act of 1969, 42 U.S.C. 4332(2)(C), the National Park Service (NPS) announces the availability of a Draft Environmental Impact Statement (Draft EIS) for the Acquisition of Florida Power and Light Company Land in the East Everglades Expansion Area, Everglades National Park, Florida. DATES: The NPS will accept comments on the Draft EIS from the public for a period of 60 days following publication of the Environmental Protection Agency’s Notice of Availability in the Federal Register. We will announce the dates, times, and location for a public meeting to solicit comments on the Draft EIS through the NPS Planning, Environment, and Public Comment (PEPC) Web site at http:// parkplanning.nps.gov/EVER; the Web site of Everglades National Park at www.nps.gov/ever; and media outlets. ADDRESSES: Electronic copies of the Draft EIS will be available online at http://parkplanning.nps.gov/EVER. A limited number of compact disks and printed copies will be also available at the Park headquarters, Everglades National Park, 40001 State Highway 9336, Homestead, Florida 33034–6733. FOR FURTHER INFORMATION CONTACT: Brien Culhane, Everglades National Park, 40001 State Road 9336, Homestead, FL 33034–6733 or by telephone at (305) 242–7717. SUMMARY: E:\FR\FM\15JAN1.SGM 15JAN1

Agencies

[Federal Register Volume 79, Number 10 (Wednesday, January 15, 2014)]
[Notices]
[Page 2688]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00636]


-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

National Park Service

[NPS-IMR-YELL-14103; PPIMYELL82, PPMRSNR1Z.AM0000]


Remote Vaccination Program To Reduce the Prevalence of 
Brucellosis in Yellowstone Bison, Final Environmental Impact Statement, 
Yellowstone National Park, Wyoming

AGENCY: National Park Service, Interior.

ACTION: Notice of Availability.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the National Environmental Policy Act of 1969, 42 
U.S.C. 4332(2)(C), the National Park Service announces the availability 
of a Final Environmental Impact Statement for the Remote Vaccination 
Program to Reduce the Prevalence of Brucellosis in Yellowstone Bison, 
Yellowstone National Park, Wyoming.

DATES: The National Park Service will execute a Record of Decision 
(ROD) no sooner than 30 days following publication by the Environmental 
Protection Agency of the Notice of Availability of the Final 
Environmental Impact Statement.

ADDRESSES: Information will be available for public inspection online 
at http://parkplanning.nps.gov/YELL, and at the Yellowstone Center for 
Resources, P.O. Box 168, Yellowstone National Park, Wyoming 82190, 
telephone (307) 344-2203.

FOR FURTHER INFORMATION CONTACT: Jennifer Carpenter or Rick Wallen, 
P.O. Box 168, Yellowstone National Park, WY 82190, telephone (307) 344-
2203, or by email at YELL_Bison_Management@NPS.GOV.

SUPPLEMENTARY INFORMATION: The document describes three management 
alternatives including a no-action alternative and the NPS preferred 
alternative. The anticipated environmental impacts of those 
alternatives are analyzed. The final document also includes responses 
to substantive comments from the public, from traditionally associated 
American Indian tribes, and from government agencies.
    Alternative A (No Action) describes the currently authorized 
syringe vaccination of calves and yearlings that are periodically 
captured at the park boundary. Alternative B describes a proposed 
action to continue the syringe vaccination program and add a field 
program to remotely vaccinate calves and yearlings using a pneumatic 
rifle to deliver an absorbable projectile with a vaccine payload to 
muscle tissue. Alternative C describes a program to continue the 
syringe vaccination action and add a field program to remotely 
vaccinate calves, yearlings, and adult females as is described in 
Alternative B.
    The National Park Service has identified Alternative A, No Action, 
as its preferred alternative based on substantial uncertainties 
associated with vaccine efficacy, delivery, duration of the vaccine-
induced protective immune response, diagnostics, and bison behavior, 
existing management flexibilities, and evaluation of public comments. 
Consistent with the 2000 Interagency Bison Management Plan (IBMP), the 
preferred alternative would continue hand-syringe vaccination of bison 
at capture facilities near the park boundary and conduct monitoring and 
research on the relationship between vaccine-induced immune responses 
and protection from clinical disease (e.g., abortions). Also, selective 
culling of potentially infectious bison based on age and diagnostic 
test results may be continued at capture facilities to reduce the 
number of abortions that maintain the disease. The preferred 
alternative would continue the adaptive management program, as 
described in the 2000 Record of Decision for the IBMP and subsequent 
adaptive management adjustments, to learn more about the disease 
brucellosis and answer uncertainties, as well as to develop or improve 
suppression techniques that could be used to facilitate effective 
outcomes, minimize adverse impacts, and lower operational costs of 
efforts to reduce brucellosis prevalence in the future.
    The National Park Service would also continue to work with other 
federal and state agencies, American Indian tribes, academic 
institutions, non-governmental organizations, and other interested 
parties to develop holistic management approaches, monitoring and 
research projects that could be conducted to improve the adaptive 
management decision process, and better vaccines, delivery methods, and 
diagnostics for reducing the prevalence of brucellosis in bison and elk 
and transmissions to cattle.

    Dated: October 31, 2013.
Laura E. Joss,
Acting Regional Director, Intermountain Region, National Park Service.
[FR Doc. 2014-00636 Filed 1-14-14; 8:45 am]
BILLING CODE 4312-CB-P